See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Baseball
Natural Disasters
Stock Markets
Social Media
Tariffs
UK Economy
Taxes
Soccer
Donald Trump
Education
Senate
Artificial Intelligence
Published • loading... • Updated

Corcept Therapeutics (NASDAQ:CORT) Shares Gap Up After Analyst Upgrade

Summary by defenseworld.net
Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Free Report)’s stock price gapped up before the market opened on Monday after Truist Financial raised their price target on the stock from $76.00 to $150.00. The stock had previously closed at $54.63, but opened at $94.93. Truist Financial currently has a buy rating on the stock. Corcept Therapeutics shares last traded at $99.93, with a volume of 3,955,938 shares changing hands. Several other …

3 Articles

All
Left
Center
1
Right
defenseworld.netdefenseworld.net
Center

Corcept Therapeutics (NASDAQ:CORT) Shares Gap Up After Analyst Upgrade

Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Free Report)’s stock price gapped up before the market opened on Monday after Truist Financial raised their price target on the stock from $76.00 to $150.00. The stock had previously closed at $54.63, but opened at $94.93. Truist Financial currently has a buy rating on the stock. Corcept Therapeutics shares last traded at $99.93, with a volume of 3,955,938 shares changing hands. Several other …

Read Full Article
Endpoints NewsEndpoints News

Corcept shares soar after Phase 3 win in platinum-resistant ovarian cancer

Corcept Therapeutics’ oral glucocorticoid receptor antagonist has improved survival outcomes in a late-stage test in patients with a challenging form of ovarian cancer, sending its shares up 76% at market open on Monday. The California ...

Read Full Article
curetoday.comcuretoday.com

Relacorilant Plus Chemo Meets Primary Goal in Ovarian Cancer Trial

The phase 3 trial showed relacorilant with chemotherapy improved progression-free and overall survival in platinum-resistant ovarian cancer.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

curetoday.com broke the news in on Monday, March 31, 2025.
Sources are mostly out of (0)

Similar News Topics

Stock Markets

Stock Markets

United States

United States

US Economy

US Economy

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal